Citation

Jafferany M. Prim. Care Companion J. Clin. Psychiatry 2007; 9(3): 203-213.

Copyright

(Copyright © 2007, Physicians Postgraduate Press)

DOI

10.4088/pcc.v09n0306

PMID

unavailable

Abstract

OBJECTIVE: This review focuses on classification and description of and current treatment recommendations for psychocutaneous disorders. Medication side effects of both psychotropic and dermatologic drugs are also considered. Data Sources: A search of the literature from 1951 to 2004 was performed using the MEDLINE search engine. English-language articles were identified using the following search terms: skin and psyche, psychiatry and dermatology, mind and skin, psychocutaneous, and stress and skin. Data Synthesis: The psychotropic agents most frequently used in patients with psychocutaneous disorders are those that target anxiety, depression, and psychosis. Psychiatric side effects of dermatologic drugs can be significant but can occur less frequently than the cutaneous side effects of psychiatric medications. In a majority of patients presenting to dermatologists, effective management of skin conditions requires consideration of associated psychosocial factors. For some dermatologic conditions, there are specific demographic and personality features that commonly associate with disease onset or exacerbation.

CONCLUSIONS: More than just a cosmetic disfigurement, dermatologic disorders are associated with a variety of psychopathologic problems that can affect the patient, his or her family, and society together. Increased understanding of biopsychosocial approaches and liaison among primary care physicians, psychiatrists, and dermatologists could be very useful and highly beneficial.

Language: en

Keywords

human; suicide; MEDLINE; psychotherapy; suicidal ideation; depression; anxiety; psychosis; personality; lithium; comorbidity; acne; isotretinoin; mood disorder; stress management; review; social psychiatry; eating disorder; disease classification; anticonvulsive agent; antidepressant agent; anxiolytic agent; barbituric acid derivative; neuroleptic agent; doxepin; amitriptyline; clomipramine; cognitive defect; fluoxetine; mirtazapine; nortriptyline; paroxetine; serotonin uptake inhibitor; sertraline; virus infection; neurosis; cognitive therapy; anxiety disorder; leisure; psychotropic agent; psychophysiology; electroconvulsive therapy; haloperidol; trifluoperazine; mental stress; benzodiazepine derivative; demography; olanzapine; risperidone; weight gain; emotional stress; disease exacerbation; delirium; naltrexone; corticosteroid; erythema; postherpetic neuralgia; systemic lupus erythematosus; chlorpromazine; gabapentin; side effect; topiramate; atypical antipsychotic agent; diabetes mellitus; alopecia; hyperlipidemia; photosensitivity; psoriasis; pruritus; hypnosis; parasitosis; low drug dose; body dysmorphic disorder; obsessive compulsive disorder; pimozide; feedback system; phobia; delusional parasitosis; dermatitis; information retrieval; drug eruption; drug hypersensitivity; erythema multiforme; Stevens Johnson syndrome; trigeminus neuralgia; urticaria; hair loss; Wart virus; rosacea; exfoliative dermatitis; toxic epidermal necrolysis; mood change; trichotillomania; contact dermatitis; hyperpigmentation; family stress; hyperhidrosis; life stress; dermatology; nail disease; mucosa inflammation; stomatitis; petechia; drug targeting; vasculitis; atopic dermatitis; maculopapular rash; herpes simplex; herpes zoster; lupus like syndrome; purpura; sensory dysfunction; skin discoloration; vesicular rash; alopecia areata; aphthous stomatitis; atopy; behavior theory; Darier disease; dermatitis artefacta; dyshidrosis; erythema nodosum; geographic tongue; hair color; keratosis palmoplantaris; leukocytoclastic vasculitis; leukonychia; mycosis fungoides; porphyria; psychocutaneous disease; purpuric rash; pustular psoriasis; scleroderma; seborrheic dermatitis; skin sensation; suppurative hidradenitis; vaginal ulcer; verruca vulgaris; vitiligo